1. Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?
   Erik Vassella et al, 2015, Oncotarget CrossRef
2. Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells
   Vincent Geoghegan et al, 2017, Nature Communications CrossRef
3. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy
   Xintao Gao et al, 2023, Journal of Medicinal Chemistry CrossRef
4. Lung cancer and molecular targeted drugs
   Katsuyuki Kiura et al, 2013, Okayama Igakkai Zasshi (Journal of Okayama Medical Association) CrossRef
5. Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth
   Rosalin Mishra et al, 2021, International Journal of Molecular Sciences CrossRef
6. Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
   Jennifer Wheler et al, 2013, Oncotarget CrossRef
7. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
   William H. Chappell et al, 2011, Oncotarget CrossRef